%0 Journal Article
%9 ACL : Articles dans des revues avec comité de lecture répertoriées par l'AERES
%A Mbala-Kingebeni, P.
%A Aziza, A.
%A Di Paola, N.
%A Wiley, M. R.
%A Makiala-Mandanda, S.
%A Caviness, K.
%A Pratt, C. B.
%A Ladner, J. T.
%A Kugelman, J. R.
%A Prieto, K.
%A Chitty, J. A.
%A Larson, P. A.
%A Beitzel, B.
%A Ayouba, Ahidjo
%A Vidal, Nicole
%A Karhemere, S.
%A Diop, M.
%A Diagne, M. M.
%A Faye, M.
%A Faye, O.
%A Aruna, A.
%A Nsio, J.
%A Mulangu, F.
%A Mukadi, D.
%A Mukadi, P.
%A Kombe, J.
%A Mulumba, A.
%A Villabona-Arenas, C. J.
%A Pukuta, E.
%A Gonzalez, J.
%A Bartlett, M. L.
%A Sozhamannan, S.
%A Gross, S. M.
%A Schroth, G. P.
%A Tim, R.
%A Zhao, J. H. J.
%A Kuhn, J. H.
%A Diallo, B.
%A Yao, M.
%A Fall, I. S.
%A Ndjoloko, B.
%A Mossoko, M.
%A Lacroix, Audrey
%A Delaporte, E.
%A Sanchez-Lockhart, M.
%A Sall, A. A.
%A Muyembe-Tamfum, J. J.
%A Peeterst, M.
%A Palacios, G.
%A Ahuka-Mundeke, S.
%T Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo : a rapid genomic assessment
%D 2019
%L fdi:010075729
%G ENG
%J Lancet Infectious Diseases
%@ 1473-3099
%K REPUBLIQE DEMOCRATIQUE DU CONGO
%M ISI:000468624500039
%N 6
%P 648-657
%R 10.1016/s1473-3099(19)30118-5
%U https://www.documentation.ird.fr/hor/fdi:010075729
%> https://www.documentation.ird.fr/intranet/publi/2019/06/010075729.pdf
%V 19
%W Horizon (IRD)
%X Background The real-time generation of information about pathogen genomes has become a vital goal for transmission analysis and characterisation in rapid outbreak responses. In response to the recently established genomic capacity in the Democratic Republic of the Congo, we explored the real-time generation of genomic information at the start of the 2018 Ebola virus disease (EVD) outbreak in North Kivu Province. Methods We used targeted-enrichment sequencing to produce two coding-complete Ebola virus genomes 5 days after declaration of the EVD outbreak in North Kivu. Subsequent sequencing efforts yielded an additional 46 genomes. Genomic information was used to assess early transmission, medical countermeasures, and evolution of Ebola virus. Findings The genomic information demonstrated that the EVD outbreak in the North Kivu and Ituri Provinces was distinct from the 2018 EVD outbreak in Equateur Province of the Democratic Republic of the Congo. Primer and probe mismatches to Ebola virus were identified in silico for all deployed diagnostic PCR assays, with the exception of the Cepheid GeneXpert GP assay. Interpretation The first two coding-complete genomes provided actionable information in real-time for the deployment of the rVSVAG-ZEBOV-GP Ebola virus envelope glycoprotein vaccine, available therapeutics, and sequence-based diagnostic assays. Based on the mutations identified in the Ebola virus surface glycoprotein (GP(1,2)) observed in all 48 genomes, deployed monoclonal antibody therapeutics (mAb114 and ZMapp) should be efficacious against the circulating Ebola virus variant. Rapid Ebola virus genomic characterisation should be included in routine EVD outbreak response procedures to ascertain efficacy of medical countermeasures.
%$ 052 ; 050